Funding Opportunities and Notices

NIBIB is passing along the weekly NIH Guide for Grants and Contracts Table of Contents. Scroll down for information and opportunities that may be of interest. Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts   January 7, 2022 Policy Notices Publication of the Revised NIH Grants Policy Statement (Rev. December 2021) for Fiscal Year 2022 (NOT-OD-22-050) National Institutes of Health General Notices Notice of Clarification Regarding Institutional Eligibility for PAR-21-173 "Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)" (NOT-GM-22-024) National Institute of General Medical Sciences Notice of Clarification Regarding Institutional Eligibility for PAR-21-169 "Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)" (NOT-GM-22-025) National Institute of General Medical Sciences Notice of NIMH Intent to Issue Funding Opportunity Announcements and Notice of Special Interest for COVID-19 and Mental Health Research (NOT-MH-22-105) National Institute of Mental Health Request for Information: Soliciting Input on Research Priorities for Amyotrophic Lateral Sclerosis (ALS) (NOT-NS-22-056) National Institute of Neurological Disorders and Stroke Notices of Changes to Funding Opportunities Notice of Change to Key Dates for NIDA PAR-21-183, " Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)" (NOT-DA-22-001) National Institute on Drug Abuse Notice of Change to Award Information for RFA-DK-21-027, "National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD) (U2C - Clinical Trial Not Allowed)" (NOT-DK-22-008) National Institute of Diabetes and Digestive and Kidney Diseases Notice of Change to Award Information for RFA-DK-21-035, "Coordinating Unit for the National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD) (U24 - Clinical Trial Not Allowed)" (NOT-DK-22-009) National Institute of Diabetes and Digestive and Kidney Diseases Notice to Extend the Application Due Date for RFA-FD-22-004 - "Renewal - Cooperative Agreement to Support the Joint Institute for Food Safety and Applied Nutrition, JIFSAN (U01) Clinical Trial Not Allowed" (NOT-FD-22-003) Food and Drug Administration Notice to Extend the Application and Letter of Intent Due Dates for RFA-FD-22-013 - "Development of Advanced Analytical Methods for Analyzing Diastereomer Compositions in Oligonucleotides (U01) Clinical Trial Not Allowed" (NOT-FD-22-004) Food and Drug Administration Notice of Change to Award Budget for PHS 2021-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications (NOT-OD-22-043) Office of the Director, NIH Notices of Intent to Publish Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiative (Phase III) (NOT-OD-22-051) Office of the Director, NIH National Institute of Mental Health Notices of Special Interest Notice of Special Interest (NOSI): Novel Approaches to Diagnosing and Studying Clinical Alzheimer's Disease and Related Dementias (NOT-AG-21-036) National Institute on Aging Notice of Special Interest (NOSI): In vivo Synaptic Function in Alzheimer's Disease and Related Dementias (NOT-AG-21-038) National Institute on Aging Notice of Special Interest (NOSI): Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (NOT-AG-21-040) National Institute on Aging Notice of Special Interest (NOSI): Capturing Complexity in the Molecular and Cellular Mechanisms Involved in the Etiology of Alzheimer's Disease (NOT-AG-21-041) National Institute on Aging Notice of Special Interest (NOSI): Deciphering the Glycosylation Code of Alzheimer's Disease (NOT-AG-21-042) National Institute on Aging Notice of Special Interest (NOSI): Sensory and Motor System Changes as Predictors of Preclinical Alzheimers Disease. (NOT-AG-21-044) National Institute on Aging Notice of Special Interest (NOSI): Opportunities for Research in Epidemiology of Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) and Cognitive Resilience (NOT-AG-21-045) National Institute on Aging Notice of Special Interest (NOSI): Dementia Care Research: Programs and services for persons with dementia (NOT-AG-21-046) National Institute on Aging Notice of Special Interest (NOSI): Behavioral and Social Science Priority Areas in Dementia Care Partner/Caregiver Research (NOT-AG-21-047) National Institute on Aging Notice of Special Interest (NOSI): Digital Technology for Early Detection and Monitoring of Alzheimers Disease and Related Dementias (NOT-AG-21-048) National Institute on Aging Notice of Special Interest (NOSI): Dementia Care Workforce for Those Living with Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) (NOT-AG-21-049) National Institute on Aging Notice of Special Interest (NOSI): Sex and Gender Differences in Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) (NOT-AG-21-050) National Institute on Aging Office of Research on Women's Health Notice of Special Interest (NOSI): Human Cell Biology of Alzheimer's Disease Genetic Variants (NOT-AG-21-052) National Institute on Aging Notice of Special Interest (NOSI): Role of Age-Associated Metabolic Changes in Alzheimer's Disease (NOT-AG-21-053) National Institute on Aging Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors (NOT-CA-22-029) National Cancer Institute Notice of Special Interest (NOSI): Administrative Supplements to Support Undergraduate Summer Research Experiences (NOT-GM-22-009) National Institute of General Medical Sciences Notice of Special Interest: Development and Implementation of Clinical Informatics Tools to Enhance Patients Use of Genomic Information (NOT-HG-22-011) National Human Genome Research Institute Notice of Special Interest (NOSI): BRAIN Initiative: Translation of Groundbreaking Technologies from Early-stage Development through Early Clinical Study via Blueprint MedTech (NOT-NS-22-052) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Office of Behavioral and Social Sciences Research Funding Opportunities Limited Competition: Development and Renovation of Housing, Breeding, and Research Spaces for Existing NIH-supported NHP Colonies (C06 Clinical Trial Not Allowed) (PAR-21-363) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Application Receipt Date(s): March 15, 2022 Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) (PAR-22-057) National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Neurological Disorders and Stroke Office of Research on Women's Health Application Receipt Date(s): May 01, 2023 High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) (PAR-22-079) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs National Institute of General Medical Sciences Application Receipt Date(s): Multiple dates, see announcement. Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) (PAR-22-080) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs National Institute of General Medical Sciences Application Receipt Date(s): Multiple dates, see announcement. Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed) (PAR-22-081) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs National Institute of General Medical Sciences Application Receipt Date(s): Multiple dates, see announcement. Biomedical Research Facilities (C06 Clinical Trial Not Allowed) (PAR-22-088) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Application Receipt Date(s): March 15, 2022 NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional) (PAR-22-362) National Institute on Aging Application Receipt Date(s): Not Applicable Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs) (U24 Clinical Trial Optional) (RFA-AG-23-006) National Institute on Aging Application Receipt Date(s): May 16, 2022 Pharmacokinetic and Pharmacodynamic (PK/PD) Studies of mTOR Inhibitors on Aging-Related Indications (U01 Clinical Trial Required) (RFA-AG-23-008) National Institute on Aging Application Receipt Date(s): June 15, 2022 Host Immunity and Novel Immunization Strategies for Clostridioides difficile Infection (CDI) (U19 Clinical Trial Not Allowed) (RFA-AI-22-001) National Institute of Allergy and Infectious Diseases Application Receipt Date(s): May 20, 2022 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) (RFA-CA-22-005) National Cancer Institute Application Receipt Date(s): September 22, 2022 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) (RFA-CA-22-006) National Cancer Institute Application Receipt Date(s): September 22, 2022 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) (RFA-CA-22-007) National Cancer Institute Application Receipt Date(s): September 22, 2022 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) (RFA-CA-22-008) National Cancer Institute Application Receipt Date(s): September 22, 2022 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) (RFA-CA-22-009) National Cancer Institute Application Receipt Date(s): September 22, 2022 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) (RFA-CA-22-010) National Cancer Institute Application Receipt Date(s): September 22, 2022 U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) (RFA-CA-22-011) National Cancer Institute John E. Fogarty International Center Application Receipt Date(s): March 30, 2022 HEAL Initiative: HEAL Data2Action Modeling and Economic Resource Center (U24 Clinical Trial Optional) (RFA-DA-22-049) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt Date(s): March 10, 2022 HEAL Initiative: HEAL Data2Action Research Adoption Support Center (U2C Clinical Trial Optional) (RFA-DA-22-050) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt Date(s): March 25, 2022 HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional) (RFA-DA-22-051) National Institute on Drug Abuse National Center for Complementary and Integrative Health Application Receipt Date(s): March 10, 2022 HEAL Initiative: HEAL Data2Action (HD2A) Data Infrastructure Support Center (U24 Clinical Trial Optional) (RFA-DA-22-052) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt Date(s): March 10, 2022 Elucidating the heterogeneity of impaired awareness of hypoglycemia in Type 1 Diabetes (T1D) Clinical Centers (U01 Clinical Trial Required) (RFA-DK-21-020) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): March 31, 2022 Elucidating the heterogeneity of impaired awareness of hypoglycemia in Type 1 Diabetes (T1D) - Biostatistics Research Center (U01 Clinical Trial Not Allowed) (RFA-DK-21-036) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): March 31, 2022 Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed) (RFA-ES-22-001) National Institute of Environmental Health Sciences Application Receipt Date(s): February 13, 2024 Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional) (RFA-HL-23-003) National Heart, Lung, and Blood Institute Application Receipt Date(s): March 28, 2024 Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) (RFA-MD-22-003) National Institute on Minority Health and Health Disparities National Center for Advancing Translational Sciences Application Receipt Date(s): April 04, 2022 Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) (RFA-MD-22-004) National Institute on Minority Health and Health Disparities National Center for Advancing Translational Sciences National Heart, Lung, and Blood Institute National Institute on Aging National Institute of Biomedical Imaging and Bioengineering National Institute on Drug Abuse National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health Application Receipt Date(s): April 04, 2022 Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional) (RFA-MH-22-170) National Institute of Mental Health National Institute on Drug Abuse Office of Behavioral and Social Sciences Research Application Receipt Date(s): May 10, 2022 Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional) (RFA-MH-22-171) National Institute of Mental Health National Institute on Drug Abuse Office of Behavioral and Social Sciences Research Application Receipt Date(s): May 10, 2022 Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Testing Laboratories (U01 Clinical Trial Not Allowed) (RFA-NS-22-003) National Institute of Neurological Disorders and Stroke Application Receipt Date(s): March 14, 2022 Limited Competition: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-NS-22-004) National Institute of Neurological Disorders and Stroke Application Receipt Date(s): March 14, 2022 Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed) (RFA-NS-22-032) National Institute of Neurological Disorders and Stroke Application Receipt Date(s): March 14, 2022 Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection- Interventions from Small Businesses (U44 Clinical Trial Not Allowed) (RFA-NS-22-033) National Institute of Neurological Disorders and Stroke Application Receipt Date(s): March 14, 2022 HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) (RFA-NS-22-034) National Institute of Neurological Disorders and Stroke National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): Multiple dates, see announcement. NIH Funding Opportunities now available in RSS (Really Simple News Syndication) format - click here for details. To UnSubscribe to the NIH Guide Weekly TOC LISTSERV, follow the instructions here. This weekly list can be found here. To join or leave the NIBIB Listserv, please visit this webpage and complete the online form. You can also change your options for the Listserv at this site.

HOME  |  DISCLAIMER  |  POLICIES  |  ACCESSIBILITY  |  FOIA  |  NEWS  |  CONTACT US

SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute for Biomedical Imaging and Bioengineering · 9000 Rockville Pike, Building 31, Room 1C14, Bethesda, MD 20892